Biotest Pharmaceuticals Corporation
Biotest Pharmaceuticals Corporation, commonly referred to as Biotest, is a prominent player in the biopharmaceutical industry, headquartered in the United States. Founded in 1946, the company has established itself as a leader in the development and production of high-quality plasma-derived therapies and biotherapeutics, primarily focusing on immunology and haematology. With major operational regions across North America and Europe, Biotest is renowned for its innovative products, including immunoglobulins and clotting factors, which are essential for treating various medical conditions. The company’s commitment to quality and patient care has earned it a strong market position, marked by significant achievements in research and development. Biotest continues to advance the field of biopharmaceuticals, making a meaningful impact on patients' lives worldwide.
DitchCarbon Score
How does Biotest Pharmaceuticals Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biotest Pharmaceuticals Corporation's score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biotest Pharmaceuticals Corporation's reported carbon emissions
Biotest Pharmaceuticals Corporation, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may be engaged in industry-standard practices aimed at sustainability and reducing environmental impact, which is increasingly important in the pharmaceutical sector. As the industry evolves, Biotest Pharmaceuticals may adopt future initiatives to address climate change and enhance their environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biotest Pharmaceuticals Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
